Amgen Inc at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 01:45PM GMT
Mohit Bansal - Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Great. Thank you very much for joining us today. Good morning. My name is Mohit Bansal. I'm one of the biopharma analyst here at Wells Fargo. And I have great pleasure of having Amgen management team here. So with us, we have Peter Griffith from -- CFO of the company; and Dr. Dave Reese, EVP and Head of R&D of the company. Thank you very much for joining us today.

Peter H. Griffith - Amgen Inc. - Executive VP & CFO

Great to be with you, Mohit. Thank you, and thank you, Wells Fargo.

David M. Reese - Amgen Inc. - EVP of Research & Development

Thanks for having us.

Mohit Bansal - Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Thank you. So maybe Peter, I'll just turn it over to you if you want to make a brief statement and then we'll go right into Q&A.

Peter H. Griffith - Amgen Inc. - Executive VP & CFO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot